Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-23-002184

Chief Medical Officer sold 2,913 shares at $28.69 ($83,574)

  • Chief Medical Officer acquired 41,120 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2023-01-03 Grant or award +41,120 138,967 D
Ho Carole Chief Medical Officer 2023-01-04 Sale −2,913 $28.69 $83,574 175,500 I
Derivatives
Ho Carole Chief Medical Officer 2023-01-03 Grant or award · Stock Option (right to buy) +123,360 123,360 D
Open-market sales · 2,913 sh · avg $28.69 · $83,574
Loading xslF345X03/doc4.xml…